Even in a world where GLP-1 weight loss drugs seem like a miraculous weight loss solution, diet, exercise, and other healthy lifestyle changes are still needed to help people lose weight — and keep ...

The U.S. Food and Drug Administration (FDA) has approved a once-daily GLP-1 pill for weight loss called orforglipron (marketed as Foundayo) for adults with obesity or those who are overweight and have ...

Infection, delayed kidney function, kidney loss and death are all risks associated with kidney transplant surgery in obese patients. They're also some of the reasons why end-stage kidney disease ...

Exercise decreased the risk of atherosclerosis development in patients with obesity on a weight-loss maintenance program, a benefit not seen with a GLP-1 agonist during the randomized trial, a ...

The key to losing weight is to focus on diet and exercise but did you know sometimes it’s better to prioritize one over the other? If you want to lose weight, diet has better outcomes compared to ...

VIENNA — Exercise to maintain weight loss reduced atherosclerosis progression and improved cardiovascular biomarkers, while GLP-1 therapy alone didn’t, according to a randomized trial in people with ...

Women battling breast cancer can benefit from a phone-based weight loss program, according to a new study. The Breast Cancer Weight Loss (BWEL) program helped women drop excess pounds, improve their ...

Costly GLP-1 drugs such as Ozempic, Wegovy, Mounjaro and Zepbound could be covered under the new plan A move to cover expensive weight-loss drugs for Americans on Medicare and Medicaid may be in the ...

An expert explains how the new program, which launches July 1, will work and who is eligible Key Takeaways A new Medicare pilot program will offer GLP-1 weight-loss medications for $50 a month ...